You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Velcade-dexamethasone

Showing 1 - 25 of 2,435
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Plasma Cell Myeloma Trial in Atlanta (Bortezomib, Daratumumab, Dexamethasone)

Active, not recruiting
  • Plasma Cell Myeloma
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jan 10, 2023

Multiple Myeloma Trial in Saint Louis (Isatuximab, Bortezomib, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 4, 2022

Multiple Myeloma Trial (Iberdomide, Bortezomib, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jul 18, 2022

Multiple Myeloma Trial (Dara-VRd intensification, Dara-R maintenance, AHCT intensification, Dara-R maintenance, AHCT

Not yet recruiting
  • Multiple Myeloma
  • Dara-VRd intensification, Dara-R maintenance
  • +4 more
  • (no location specified)
Dec 13, 2022

Primary Systemic Amyloidosis, Light Chain Deposition Disease Trial in United States (drug, genetic, other, procedure)

Active, not recruiting
Has Results
  • Primary Systemic Amyloidosis
  • Light Chain Deposition Disease
  • Denver, Colorado
  • +6 more
Aug 24, 2022

Multiple Myeloma Trial in Worldwide (Daratumumab, velcade, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Melbourne, Australia
  • +12 more
Aug 25, 2021

Light Chain Deposition Disease, Primary Systemic Amyloidosis Trial in Canada, United States (pomalidomide, bortezomib,

Active, not recruiting
  • Light Chain Deposition Disease
  • Primary Systemic Amyloidosis
  • Denver, Colorado
  • +4 more
Jan 20, 2023

Multiple Myeloma Trial in Guangzhou (Selinexor, Bortezomib, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Guangzhou, Guangdong, China
  • +3 more
Aug 16, 2022

Plasma Cell Myeloma Trial in Rochester (Bortezomib, Daratumumab, Dexamethasone)

Recruiting
  • Plasma Cell Myeloma
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Multiple Myeloma Trial in Atlanta (Bortezomib, Lenalidomide, Dexamethasone)

Completed
  • Multiple Myeloma
  • Atlanta, Georgia
    Emory University Winship Cancer Institute
Nov 1, 2021

Newly Diagnosed Multiple Myeloma Trial in Germany (Isatuximab, Lenalidomide, Bortezomib)

Not yet recruiting
  • Newly Diagnosed Multiple Myeloma
  • Hamburg, Germany
  • +3 more
Dec 16, 2022

Multiple Myeloma Trial in Chicago, Milwaukee (Bortezomib, Isatuximab, Cyclophosphamide)

Recruiting
  • Multiple Myeloma
  • Chicago, Illinois
  • +1 more
Mar 14, 2022

High-risk Smoldering Multiple Myeloma, Multiple Myeloma Trial in Boston (Daratumumab, Bortezomib, Lenalidomide)

Recruiting
  • High-risk Smoldering Multiple Myeloma
  • Multiple Myeloma
  • Boston, Massachusetts
  • +1 more
Oct 18, 2021

Multiple Myeloma Trial in Germany, Greece (Daratumumab, Bortezomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • Berlin, Germany
  • +9 more
May 27, 2022

Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma Trial in Wuhan (Daratumumab, Carfilzomib,

Recruiting
  • Multiple Myeloma
  • +2 more
  • Wuhan, Hubei, China
    Institute of Hematology, Union Hospital, Tongji Medical College,
Nov 18, 2023

Multiple Myeloma Trial in Torino (Velcade, Melphalan, Prednisone)

Recruiting
  • Multiple Myeloma
  • Torino, TO, Italy
    Dipartimento di Biotecnologie Molecolari e Scienze per la Salute
May 25, 2022

Multiple Myeloma Trial in Denmark, Estonia, Norway (Selinexor 20 MG Oral Tablet, Bortezomib Injection, Lenalidomide capsule)

Recruiting
  • Multiple Myeloma
  • Selinexor 20 MG Oral Tablet
  • +3 more
  • Aalborg, Denmark
  • +10 more
Apr 22, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Los Angeles (drug, other, biological)

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Aug 5, 2022

Multiple Myeloma Trial in Chicago (Carfilzomib, Lenalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Chicago, Illinois
    University Of Chicago Medicine Comprehensive Cancer Center
Jun 7, 2021

Plasma Cell Myeloma Trial in Worldwide (lenalidomide, bortezomib, cyclophosphamide)

Active, not recruiting
  • Plasma Cell Myeloma
  • Nantes Cedex 01, France
  • +11 more
May 3, 2022

Multiple Myeloma, Refractory Trial in Greece, Israel (Selinexor, Dexamethasone, Bortezomib)

Recruiting
  • Multiple Myeloma, Refractory
  • Patra, Achaia, Greece
  • +15 more
Apr 4, 2022

Multiple Myeloma Trial in United States (Lenalidomide, Elotuzumab, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Atlanta, Georgia
  • +6 more
Dec 17, 2021

Multiple Myeloma Trial in United States (Bortezomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Denver, Colorado
  • +7 more
Feb 11, 2022

Multiple Myeloma Trial in France, Spain, United States (Daratumumab, Velcade, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Duarte, California
  • +21 more
Jan 17, 2023

Multiple Myeloma Trial in Worldwide (Velcade (Bortezomib), Thalidomide, Dexamethasone)

Terminated
Has Results
  • Multiple Myeloma
  • Velcade (Bortezomib)
  • +2 more
  • Graz, Austria
  • +80 more
Sep 21, 2021